-
1
-
-
0023907493
-
Interleukin-2: Inception, impact, and implications
-
Smith KA. Interleukin-2: inception, impact, and implications. Science. 1988;240:1169-1176.
-
(1988)
Science
, vol.240
, pp. 1169-1176
-
-
Smith, K.A.1
-
2
-
-
33845506881
-
Cytokine-based modulation of immune function in HIV infection
-
Levy Y. Cytokine-based modulation of immune function in HIV infection. Curr Opin HIV AIDS. 2006;1:67-71.
-
(2006)
Curr Opin HIV AIDS
, vol.1
, pp. 67-71
-
-
Levy, Y.1
-
3
-
-
17444385673
-
Partial immune reconstitution following highly active antiretroviral therapy: Can adjuvant interleukin-2 fill the gap?
-
Marchetti G, Franzetti F, Gori A. Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap? J Antimicrob Chemother. 2005;55:401-409.
-
(2005)
J Antimicrob Chemother
, vol.55
, pp. 401-409
-
-
Marchetti, G.1
Franzetti, F.2
Gori, A.3
-
4
-
-
0013610170
-
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
-
Kovacs JA, Vogel S, Albert JM, et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med. 1996;335:1350-1356.
-
(1996)
N Engl J Med
, vol.335
, pp. 1350-1356
-
-
Kovacs, J.A.1
Vogel, S.2
Albert, J.M.3
-
5
-
-
0033526641
-
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: A randomised controlled trial. ANRS 048 study group
-
Levy Y, Capitant C, Houhou S, et al. Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet. 1999;353:1923-1929.
-
(1999)
Lancet
, vol.353
, pp. 1923-1929
-
-
Levy, Y.1
Capitant, C.2
Houhou, S.3
-
6
-
-
0001027244
-
A randomized trial of high-versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection
-
Davey RT Jr, Chaitt DG, Albert JM, et al. A randomized trial of high-versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J Infect Dis. 1999;179:849-858.
-
(1999)
J Infect Dis
, vol.179
, pp. 849-858
-
-
Davey Jr, R.T.1
Chaitt, D.G.2
Albert, J.M.3
-
7
-
-
0004781509
-
Immunologic and virologie effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial
-
Davey RT Jr, Murphy RL, Graziano FM, et al. Immunologic and virologie effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial. JAMA. 2000;284:183-189.
-
(2000)
JAMA
, vol.284
, pp. 183-189
-
-
Davey Jr, R.T.1
Murphy, R.L.2
Graziano, F.M.3
-
8
-
-
0037436193
-
Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-I infection: A randomized controlled trial
-
Levy Y, Durier C, Krzysiek R, et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-I infection: a randomized controlled trial. AIDS. 2003;17:343-351.
-
(2003)
AIDS
, vol.17
, pp. 343-351
-
-
Levy, Y.1
Durier, C.2
Krzysiek, R.3
-
9
-
-
3042831250
-
CD4 cell response to 3 doses of subcutaneous interleukin 2: Meta-analysis of 3 Vanguard studies
-
Arduino RC, Nannini EC, Rodriguez-Barradas M, et al. CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies. Clin Infect Dis. 2004;39:115-122.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 115-122
-
-
Arduino, R.C.1
Nannini, E.C.2
Rodriguez-Barradas, M.3
-
10
-
-
0035822985
-
Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients
-
Gougeon ML, Rouzioux C, Liberman I, et al. Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients. AIDS. 2001;15:1729-1731.
-
(2001)
AIDS
, vol.15
, pp. 1729-1731
-
-
Gougeon, M.L.1
Rouzioux, C.2
Liberman, I.3
-
11
-
-
11144353584
-
Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection
-
Farel CE, Chaitt DG, Hahn BK, et al. Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood. 2004;103:3282-3286.
-
(2004)
Blood
, vol.103
, pp. 3282-3286
-
-
Farel, C.E.1
Chaitt, D.G.2
Hahn, B.K.3
-
12
-
-
33645027967
-
Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients
-
Keh CE, Shen JM, Hahn B, et al. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients. AIDS. 2006;20:361-369.
-
(2006)
AIDS
, vol.20
, pp. 361-369
-
-
Keh, C.E.1
Shen, J.M.2
Hahn, B.3
-
13
-
-
33748155708
-
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials
-
Lifson AR, Rhame FS, Belloso WH, et al. Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials. HIV Clin Trials. 2006;7:125-141.
-
(2006)
HIV Clin Trials
, vol.7
, pp. 125-141
-
-
Lifson, A.R.1
Rhame, F.S.2
Belloso, W.H.3
-
14
-
-
0036721196
-
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy
-
Malnati M, Broccolo F, Nozza S, et al. Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Blood. 2002;100:1575-1578.
-
(2002)
Blood
, vol.100
, pp. 1575-1578
-
-
Malnati, M.1
Broccolo, F.2
Nozza, S.3
-
15
-
-
61349197977
-
-
Agence Nationale de Recherches sur le SIDA et las hépatites virales. ANRS trials 048, 079, 082 [ILSTIM], 093 [VACCIL-2], 095 [PRIMOVAC], 101 [ESPRIT], 118 [ILIADE], 119 [INTERSTART], 122 [SILCAAT], and 123 [ETOILE], Available at: www.anrs.fr/index.php/anrs/vih_sida/clinique/ repertoire_des_etudes_cliniques. Accessed November 24, 2008.
-
Agence Nationale de Recherches sur le SIDA et las hépatites virales. ANRS trials 048, 079, 082 [ILSTIM], 093 [VACCIL-2], 095 [PRIMOVAC], 101 [ESPRIT], 118 [ILIADE], 119 [INTERSTART], 122 [SILCAAT], and 123 [ETOILE], Available at: www.anrs.fr/index.php/anrs/vih_sida/clinique/ repertoire_des_etudes_cliniques. Accessed November 24, 2008.
-
-
-
-
16
-
-
0037131199
-
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: The ILSTIM study-ANRS 082
-
Katlama C, Carcelain G, Duvivier C, et al. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study-ANRS 082. AIDS. 2002;16:2027-2034.
-
(2002)
AIDS
, vol.16
, pp. 2027-2034
-
-
Katlama, C.1
Carcelain, G.2
Duvivier, C.3
-
17
-
-
84974610155
-
-
Institut national de la santé et de la recherche médicale Unité U 720, Available at:, Accessed November 24, 2008
-
Institut national de la santé et de la recherche médicale Unité U 720. French Hospital Database on HIV (FHDH). Available at: http://ccde.fr/_fold/fl-1182178152-395.pdf. Accessed November 24, 2008.
-
French Hospital Database on HIV (FHDH)
-
-
-
20
-
-
84921009277
-
Expanded European AIDS definition
-
Ancelle-Park E. Expanded European AIDS definition. Lancet. 1993;341:441.
-
(1993)
Lancet
, vol.341
, pp. 441
-
-
Ancelle-Park, E.1
-
21
-
-
0024592074
-
The impact of confounder selection criteria on effect estimation
-
Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125-137.
-
(1989)
Am J Epidemiol
, vol.129
, pp. 125-137
-
-
Mickey, R.M.1
Greenland, S.2
-
22
-
-
4444226528
-
The epidemiology of non-Hodgkin's lymphoma
-
Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004;23:6524-6534.
-
(2004)
Oncogene
, vol.23
, pp. 6524-6534
-
-
Fisher, S.G.1
Fisher, R.I.2
-
24
-
-
61349169994
-
-
Guizard AV, Carli PM, Troussard X. Lymphome malin non Hodgkinien et Maladie de Hodgkin. In: Remontet L, Buemi A, Velten M, et al eds. Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000. Réseaux Français des registres de cancer, Hôpitaux de Lyon, Inserm, Institut de Veille Sanitaire, 2003;155-166.
-
Guizard AV, Carli PM, Troussard X. Lymphome malin non Hodgkinien et Maladie de Hodgkin. In: Remontet L, Buemi A, Velten M, et al eds. Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000. Réseaux Français des registres de cancer, Hôpitaux de Lyon, Inserm, Institut de Veille Sanitaire, 2003;155-166.
-
-
-
-
25
-
-
3042796713
-
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS
-
Grulich AE, Wan X, Law MG, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS. 2000;14:133-140.
-
(2000)
AIDS
, vol.14
, pp. 133-140
-
-
Grulich, A.E.1
Wan, X.2
Law, M.G.3
-
26
-
-
0035804852
-
Association of cancer with AIDS-related immunosuppression in adults
-
Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
-
(2001)
JAMA
, vol.285
, pp. 1736-1745
-
-
Frisch, M.1
Biggar, R.J.2
Engels, E.A.3
-
27
-
-
0035760292
-
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy
-
Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood. 2001;98:3406-3412.
-
(2001)
Blood
, vol.98
, pp. 3406-3412
-
-
Kirk, O.1
Pedersen, C.2
Cozzi-Lepri, A.3
-
28
-
-
31044447107
-
Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France
-
Bonnet F, Balestre E, Thiebaut R, et al. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Clin Infect Dis. 2006;42:411-417.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 411-417
-
-
Bonnet, F.1
Balestre, E.2
Thiebaut, R.3
-
29
-
-
0037165879
-
Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis
-
Grulich AE, Li Y, McDonald A, et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002;16:1155-1161.
-
(2002)
AIDS
, vol.16
, pp. 1155-1161
-
-
Grulich, A.E.1
Li, Y.2
McDonald, A.3
-
30
-
-
33845237838
-
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
-
Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786-3791.
-
(2006)
Blood
, vol.108
, pp. 3786-3791
-
-
Biggar, R.J.1
Jaffe, E.S.2
Goedert, J.J.3
-
31
-
-
20144381973
-
Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
-
Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 425-432
-
-
Clifford, G.M.1
Polesel, J.2
Rickenbach, M.3
-
32
-
-
0142026064
-
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients
-
Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21:3447-3453.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3447-3453
-
-
Herida, M.1
Mary-Krause, M.2
Kaphan, R.3
-
33
-
-
34047253751
-
Infectious agents as causes of non-Hodgkin lymphoma
-
Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:401-404.
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 401-404
-
-
Engels, E.A.1
-
34
-
-
33845266758
-
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study
-
Franceschi S, Polesel J, Rickenbach M, et al. Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study. Br J Cancer. 2006;95:1598-1602.
-
(2006)
Br J Cancer
, vol.95
, pp. 1598-1602
-
-
Franceschi, S.1
Polesel, J.2
Rickenbach, M.3
-
35
-
-
34047244362
-
Environmental and behavioral factors and the risk of non-Hodgkin lymphoma
-
Hartge P, Smith MT. Environmental and behavioral factors and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:367-368.
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 367-368
-
-
Hartge, P.1
Smith, M.T.2
-
36
-
-
7244224775
-
Sun exposure may protect against non-Hodgkin lymphoma: A case-control study
-
Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer. 2004;112:865-871.
-
(2004)
Int J Cancer
, vol.112
, pp. 865-871
-
-
Hughes, A.M.1
Armstrong, B.K.2
Vajdic, C.M.3
-
38
-
-
34147154891
-
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): A pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
-
Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109:3479-3488.
-
(2007)
Blood
, vol.109
, pp. 3479-3488
-
-
Wang, S.S.1
Slager, S.L.2
Brennan, P.3
-
39
-
-
10744229561
-
Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women
-
Zheng T, Holford TR, Leaderer B, et al. Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol. 2004;159:454-466.
-
(2004)
Am J Epidemiol
, vol.159
, pp. 454-466
-
-
Zheng, T.1
Holford, T.R.2
Leaderer, B.3
-
40
-
-
34047250459
-
Obesity, diet and risk of non-Hodgkin lymphoma
-
Skibola CF. Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:392-395.
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 392-395
-
-
Skibola, C.F.1
|